SCHEMBL2850803

SCHEMBL2850803

N=C(N)c1cccc(C(N)=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 7/20 0.59
▸ PRSS1 P07477 5/20 0.57
▸ PRSS2 P07478 5/20 0.57
▸ PRSS3 P35030 5/20 0.57
▸ F2 P00734 4/20 0.57
▸ C1S P09871 1/20 0.57
▸ PLG P00747 1/20 0.57
▸ F10 P00742 3/20 0.56
▸ LOXL2 Q9Y4K0 1/20 0.53
▸ F12 P00748 1/20 0.52
▸ F7 P08709 1/20 0.52
▸ F3 P13726 1/20 0.52
▸ PKM P14618 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ BLM P54132 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31021028 0.88 PARP1 (0.73) PARP1F7F3POLBCYP3A4
SCHEMBL15547311 0.88 PRSS1 (0.70) PRSS1PRSS2PRSS3F2C1S
SCHEMBL36694 0.88 PARP1 (0.73) PARP1F7F3POLBCYP3A4
SCHEMBL9271119 0.86 ATM (0.60) PRSS1PRSS2PRSS3F2C1S
Hydrochloric Acid SCHEMBL28555629 0.85 PRSS1 (0.74) PRSS1PRSS2PRSS3F2C1S
Hydrochloric Acid SCHEMBL1367509 0.85 PARP1 (0.70) PARP1F7F3POLBCYP3A4
Methane SCHEMBL688609 0.85 PARP1 (0.70) PARP1F7F3POLBCYP3A4
Water SCHEMBL7768285 0.85 PARP1 (0.70) PARP1F7F3POLBCYP3A4
Ammonia Solution, Strong SCHEMBL9121446 0.85 PARP1 (0.70) PARP1F7F3POLBCYP3A4
Hydrochloric Acid SCHEMBL28253026 0.85 PRSS1 (0.74) PRSS1PRSS2PRSS3F2C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451160-B1 PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN ICAGEN INC (US) 2010-01-13 — — EP claimed
EP-1451160-B1 PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN ICAGEN INC (US) 2010-01-13 — — EP disclosed
EP-0976722-B1 BENZAMIDINE DERIVATIVES AJINOMOTO KK (JP) 2009-03-11 — — EP disclosed
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 — — US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 — — US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 PARP1 3600/4885PRSS1 835/4885PRSS2 1361/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 PARP1 3600/4885PRSS1 835/4885PRSS2 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback